Mastoid Obliteration with Autologous Bone in Mastoidectomy Canal Wall Down Surgery: a Literature Overview
Carregando...
Citações na Scopus
33
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
Fundação Otorrinolaringologia
Citação
INTERNATIONAL ARCHIVES OF OTORHINOLARYNGOLOGY, v.20, n.1, p.76-83, 2016
Resumo
Introduction The objectives of mastoidectomy in cholesteatoma are a disease-free and dry ear, the prevention of recurrent disease, and the maintenance of hearing or the possibility to reconstruct an affected hearing mechanism. Canal wall down mastoidectomy has been traditionally used to achieve those goals with greater or lesser degrees of success. However, canal wall down is an aggressive approach, as it involves creating an open cavity and changing the anatomy and physiology of themiddle ear andmastoid. A canal wall up technique eliminates the need to destroy the middle ear and mastoid, but is associated with a higher rate of residual cholesteatoma. The obliteration technics arise as an effort to avoid the disadvantages of both techniques. Objectives Evaluate the effectiveness of the mastoid obliteration with autologous bone in mastoidectomy surgery with canal wall down for chronic otitis, with or without cholesteatoma. Data Synthesis We analyzed nine studies of case series comprehending similar surgery techniques on 1017 total cases of operated ears in both adults and children, with at least 12 months follow-up. Conclusion Mastoid Obliteration with autologous bone has been utilized for many years to present date, and it seems to be safe, low-cost, with low recurrence rates - similar to traditional canal wall down procedures and with greater water resistance and quality of life improvements.
Palavras-chave
cholesteatoma, middle ear, mastoid obliteration, mastoidectomy, otitis media, suppurative, bone and bones, tympanomastoidectomy
Referências
- Aarts MCJ, 2010, OTOLARYNG HEAD NECK, V143, P12, DOI 10.1016/j.otohns.2010.03.023
- Mehta RP, 2006, OTOLARYNG CLIN N AM, V39, P1129, DOI 10.1016/j.otc.2006.08.007
- Vercruysse JP, 2008, OTOL NEUROTOL, V29, P953, DOI 10.1097/MAO.0b013e318184f4d6
- Gantz BJ, 2005, LARYNGOSCOPE, V115, P1734, DOI 10.1097/01.MLG.0000187572.99335.cc
- Heo KW, 2014, ANN OTO RHINOL LARYN, V123, P47, DOI 10.1177/0003489414521387
- Kronenberg J, 2012, ACTA OTO-LARYNGOL, V132, P400, DOI 10.3109/00016489.2011.643456
- Sun JQ, 2010, ACTA OTO-LARYNGOL, V130, P259, DOI 10.3109/00016480903094304
- Ramsey MJ, 2004, OTOL NEUROTOL, V25, P873, DOI 10.1097/00129492-200411000-00004
- Walker PC, 2014, OTOL NEUROTOL, V35, P954
- Linthicum FH, 2002, LARYNGOSCOPE, V112, P1777, DOI 10.1097/00005537-200210000-00013
- Edfeldt L, 2013, ACTA OTO-LARYNGOL, V133, P28, DOI 10.3109/00016489.2012.707333
- Yung M, 2013, CURR OPIN OTOLARYNGO, V21, P455, DOI 10.1097/MOO.0b013e3283646521
- De Corso E, 2006, INT J PEDIATR OTORHI, V70, P1269, DOI 10.1016/j.ijporl.2006.01.006
- Edfeldt L, 2012, INT J PEDIATR OTORHI, V76, P1091, DOI 10.1016/j.ijporl.2012.04.006
- Beutner D, 2010, OTOL NEUROTOL, V31, P1399, DOI 10.1097/MAO.0b013e3181f0c662
- O'Sullivan PG, 2004, LARYNGOSCOPE, V114, P957, DOI 10.1097/00005537-200405000-00033
- PALVA T, 1979, ACTA OTO-LARYNGOL, P152
- VANHASSELT CA, 1994, J LARYNGOL OTOL, V108, P825
- 2012, Eur Arch Otorhinolaryngol, V269, P2037
- 2003, Otol Neurotol, V24, P132
- 2000, Auris Nasus Larynx, V27, P227